Bieś R, et al. The risk of methylphenidate pharmacotherapy for adults with ADHD. Pharmaceuticals (Basel). 2023;16(9):1292, 1292.

Storebø OJ et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Reviews, 2023(3).

Quintero J, Gutierrez-Casares JR, Alamo C. Molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on ADHD neurobiology: a review. Neurol Ther. 2022;11(4):1489–517.

Article  PubMed  PubMed Central  Google Scholar 

Jaeschke RR, Sujkowska E, Sowa-Kućma M. Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review. Psychopharmacology (Berl). 2021;238(10):2667–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serra M, et al. Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings. Neural Regeneration Res. 2024;19(9):1908–18.

Article  CAS  Google Scholar 

Kong N, et al. Methylphenidate causes cytotoxicity on photoreceptor cells via autophagy. Hum Exp Toxicol. 2021;40(1):71–80.

Article  CAS  PubMed  Google Scholar 

Motaghinejad M. Neuroprotective properties of minocycline against methylphenidate-induced neurodegeneration: possible role of CREB/BDNF and Akt/GSK3 signaling pathways in rat hippocampus. Neurotox Res. 2022;40(3):689–713.

Article  CAS  PubMed  Google Scholar 

Beaudin SA, et al. Methylphenidate alleviates cognitive dysfunction caused by early manganese exposure: role of catecholaminergic receptors. Prog Neuropsychopharmacol Biol Psychiatry. 2024;131:110949, 110949.

Jîtcă G, et al. Methylphenidate and its impact on redox balance and behavior. J Xenobiotics. 2025;15(5):157.

Article  Google Scholar 

Novo JP, et al. Dichotomous effect of methylphenidate on microglia and astrocytes: Insights from in vitro and animal studies. Toxicol Lett. 2023;389:1–10.

Article  CAS  PubMed  Google Scholar 

Gur I, Arieli Y, Matsliah Y. Methylphenidate and the risk of acute central nervous system oxygen toxicity: a rodent model and observational data in human divers. Diving Hyperb Med. 2024;54(3):168.

Article  PubMed  PubMed Central  Google Scholar 

Shahabi MJ, et al. Simvastatin neuroprotective properties against methylphenidate-induced neurodegeneration: histological and behavioral evidence. Adv Biomed Res. 2025;14(1):111.

Motaghinejad M, et al. Minocycline protects against neuronal mitochondrial dysfunction and cognition impairment. Acta Neurobiol Exp. 2023;83(1):71–83.

Article  Google Scholar 

Ommati MM, et al. Pesticide-induced alterations in locomotor activity, anxiety, and depression-like behavior are mediated through oxidative stress-related autophagy: a persistent developmental study in mice. J Agric Food Chem. 2024;72(19):11205–20.

Article  CAS  PubMed  Google Scholar 

Gomaa AA, et al. Repurposing aprepitant: can it protect against doxorubicin-induced chemobrain beyond its antiemetic role? Life Sci. 2024;359:123210, 123210.

El-Deeb AM, et al. Novel trajectories of the NK1R antagonist aprepitant in rotenone-induced Parkinsonism-like symptoms in rats: Involvement of ERK5/KLF4/p62/Nrf2 signaling axis. Chemico-Biol Interact. 2023;380:110562.

Article  CAS  Google Scholar 

Mohyeldin RH, et al. Aprepitant boasted a protective effect against olanzapine-induced metabolic syndrome and its subsequent hepatic, renal, and ovarian dysfunction; Role of IGF1/p-AKT/FOXO1 and NFκB/IL-1β/TNF-α signaling pathways in female Wistar albino rats. Biochem Pharmacol. 2024;221:116020.

Article  CAS  PubMed  Google Scholar 

Jin P, et al. Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage. J Neuroinflamm. 2022;19(1):198.

Article  CAS  Google Scholar 

Badyal P, et al. Aprepitant as plausible inhibitor of MAPK/ERK2 pathway to ameliorate neurological deficits post traumatic brain injury. Med Hypotheses. 2022;165:110909.

Article  CAS  Google Scholar 

Hassan HA. Aprepitant’s roles in abating seizures, behavioral, and cognitive deficits in mice model of epilepsy. Epilepsy Behav. 2024;159:110028.

Article  Google Scholar 

Mannangatti P, et al. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward. Psychopharmacology. 2017;234(4):695–705.

Article  CAS  PubMed  Google Scholar 

Percie du Sert N, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. J Cereb Blood Flow Metabolism. 2020;40(9):1769–77.

Article  Google Scholar 

Gerasimov MR, et al. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther. 2000;295(1):51–7.

Article  CAS  PubMed  Google Scholar 

Cheng J, et al. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors. Biol Psychiatry. 2014;76(12):953–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seto Y, et al. Diurnal variations of neurokinin-1 receptor defines dosing time-dependent differences in antitumor effects of aprepitant in mice. J Pharmacol Sci. 2025;158(3):193–8.

Article  CAS  PubMed  Google Scholar 

Berger M, et al. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. J Hepatol. 2014;60(5):985–94.

Article  CAS  PubMed  Google Scholar 

Lim R, et al. An FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orally. J Gastrointest Surg. 2008;12(10):1754–61.

Article  PubMed  Google Scholar 

Kose D, et al. Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties. J Pharm Pharmacol. 2021;73(10):1302–9.

Article  PubMed  Google Scholar 

Khalilzadeh M, et al. Aprepitant mitigates paclitaxel-induced neuropathic pain in rats via suppressing inflammatory pathways in dorsal root ganglia. Drug Chem Toxicol. 2025;48(1):62–71.

Article  CAS  PubMed  Google Scholar 

Al Shoyaib A, Archie SR, Karamyan VT. Intraperitoneal route of drug administration: should it be used in experimental animal studies? Al Shoyaib, Archie and Karamyan. Pharm Res. 2020;37(1):12.

Article  CAS  Google Scholar 

Mathis DM, Furman JL, Norris CM. Preparation of acute hippocampal slices from rats and transgenic mice for the study of synaptic alterations during aging and amyloid pathology. J Vis Exp, 2011(49).

Aboghazleh R, et al. Rodent brain extraction and dissection: A comprehensive approach. MethodsX. 2024;12:102516.

Article  CAS  PubMed  Google Scholar 

Wang J, et al. GSTO1 acts as a mediator in sodium fluoride-induced alterations of learning and memory related factors expressions in the hippocampus cell line. Chemosphere. 2019;226:201–9.

Article  CAS  PubMed  Google Scholar 

Yuan J, et al. Detrimental effects of sodium fluoride on the expression of insulin receptor in the olfactory bulb and hippocampus of male mice. Biol Trace Elem Res. 2020;198(1):216–23.

Article  CAS  PubMed  Google Scholar 

Manthari RK, et al. Arsenic induces autophagy in developmental mouse cerebral cortex and hippocampus by inhibiting PI3K/Akt/mTOR signaling pathway: involvement of blood–brain barrier’s tight junction proteins. Arch Toxicol. 2018;92(11):3255–75.

Article  CAS  PubMed  Google Scholar 

Heidari R, Ommati MM, Niknahad H. Methods for measuring brain mitochondrial impairment and oxidative stress in hepatic encephalopathy. In: Experimental and Clinical Methods in Hepatic Encephalopathy Research. Springer; 2025. p. 293–313.

Gould TD, Dao DT, Kovacsics CE. The open field test. In: Mood and anxiety related phenotypes in mice: Characterization using behavioral tests. 2009. p. 1–20.

Seibenhener ML. Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. 2015;2015(96):e52434.

Google Scholar 

Hu X, et al. Arsenic exposure induced anxiety-like behaviors in male mice via influencing the GABAergic Signaling in the prefrontal cortex. Environ Sci Pollut Res. 2023;30(36):86352–64.

Article  CAS  Google Scholar 

Ommati MM, et al. Taurine treatment provides neuroprotection in a mouse model of manganism. Biol Trace Elem Res. 2019;190(2):384–95.

Article  CAS  PubMed  Google Scholar 

Ghafarimoghadam M, et al. A review of behavioral methods for the evaluation of cognitive performance in animal models: current techniques and links to human cognition. Physiol Behav. 2022;244:113652.